Amplia Therapeutics Statistics

Total Valuation

ASX:ATX has a market cap or net worth of AUD 20.95 million. The enterprise value is 16.45 million.

Market Cap	20.95M
Enterprise Value	16.45M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ATX has 387.95 million shares outstanding. The number of shares has increased by 15.38% in one year.

Current Share Class	n/a
Shares Outstanding	387.95M
Shares Change (YoY)	+15.38%
Shares Change (QoQ)	+30.77%
Owned by Insiders (%)	14.59%
Owned by Institutions (%)	14.51%
Float	267.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.14
PB Ratio	1.64
P/TBV Ratio	4.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.66
EV / Sales	4.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.96

Financial Position

The company has a current ratio of 4.35, with a Debt / Equity ratio of 0.00.

Current Ratio	4.35
Quick Ratio	4.21
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-71.81

Financial Efficiency

Return on equity (ROE) is -44.96% and return on invested capital (ROIC) is -26.21%.

Return on Equity (ROE)	-44.96%
Return on Assets (ROA)	-24.61%
Return on Invested Capital (ROIC)	-26.21%
Return on Capital Employed (ROCE)	-48.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.92% in the last 52 weeks. The beta is 0.77, so ASX:ATX's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-16.92%
50-Day Moving Average	0.07
200-Day Moving Average	0.10
Relative Strength Index (RSI)	37.36
Average Volume (20 Days)	533,731

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ATX had revenue of AUD 3.41 million and -6.19 million in losses. Loss per share was -0.03.

Revenue	3.41M
Gross Profit	3.01M
Operating Income	-6.25M
Pretax Income	-6.19M
Net Income	-6.19M
EBITDA	-6.24M
EBIT	-6.25M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 4.56 million in cash and 54,987 in debt, giving a net cash position of 4.50 million or 0.01 per share.

Cash & Cash Equivalents	4.56M
Total Debt	54,987
Net Cash	4.50M
Net Cash Per Share	0.01
Equity (Book Value)	12.77M
Book Value Per Share	0.05
Working Capital	4.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.76 million and capital expenditures -2,616, giving a free cash flow of -2.76 million.

Operating Cash Flow	-2.76M
Capital Expenditures	-2,616
Free Cash Flow	-2.76M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 88.23%, with operating and profit margins of -183.29% and -181.41%.

Gross Margin	88.23%
Operating Margin	-183.29%
Pretax Margin	-181.41%
Profit Margin	-181.41%
EBITDA Margin	-182.97%
EBIT Margin	-183.29%
FCF Margin	n/a

Dividends & Yields

ASX:ATX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.38%
Shareholder Yield	-15.38%
Earnings Yield	-29.54%
FCF Yield	-13.17%

Stock Splits

The last stock split was on April 30, 2018. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 30, 2018
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:ATX has an Altman Z-Score of -6.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.65
Piotroski F-Score	n/a